Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?
about
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophreniaA conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.Removing obstacles in neuroscience drug discovery: the future path for animal models.Caffeine impairs the acquisition and retention, but not the consolidation of Pavlovian conditioned freezing in miceSSR504734 enhances basal expression of prepulse inhibition but exacerbates the disruption of prepulse inhibition by apomorphine.Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice.Habituation and prepulse inhibition of acoustic startle in rodentsPrepulse inhibition in HIV-associated neurocognitive disorders.Mouse pharmacological models of cognitive disruption relevant to schizophrenia.Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapyPrepulse inhibition of startle response: recent advances in human studies of psychiatric disease.Predictive animal models of mania: hits, misses and future directions.Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in ratsAge-associated improvements in cross-modal prepulse inhibition in miceHabituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors.Developing translational animal models for symptoms of schizophrenia or bipolar maniaUsing the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Nuclear receptor TLX stimulates hippocampal neurogenesis and enhances learning and memory in a transgenic mouse modelTandospirone, a 5-HT1A partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia.Antipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression.
P2860
Q21129280-D2D86877-090D-45DD-8BA6-80E41B59DD4BQ26269908-33095F93-7AEC-4732-8751-4CBB96DEBE58Q27001119-0D0E9812-B6AE-48E3-B72C-AAB0E1115ABEQ28755229-00A7BD34-1960-45E8-9104-CB19B9E5989AQ30392536-5D33F9E6-9F44-42CD-9C76-2B010FD343AFQ30427289-EFE62A15-E5B0-46C1-9273-1AC740AE8E7CQ30448782-F192FB20-7BA4-4B9A-B3DC-F72F18A22181Q30450016-138711E9-B3C0-47E4-87F2-ED0669ACC3EFQ30451688-86404B9D-9F14-4EAE-AB5E-3A8184F5E9F8Q30457807-EABC9A4E-E941-4154-BD1C-D1786745C586Q30457808-F3E452E2-F422-4BA4-8C4D-FAA724EA930AQ30458053-8278277A-4F98-453E-B4C4-B5E734112AE4Q30462823-30401887-5389-4D7F-928B-9AAB48172546Q30472946-72B2E8FA-A92F-4E0A-8013-9CB86ECE09D5Q30475551-FBC45BE8-2C63-4319-BEF1-D153F125559DQ30479796-936C19DC-9CBD-4DA9-BB0B-87CE54CC6A91Q30487857-86438CBB-EEE5-4852-890B-B61BF436A147Q30489404-0E1FCF51-2DE6-4096-9995-A6F4250E925FQ33834977-019896F1-7892-4F69-8B5A-7F4D7DDB2C28Q34127055-CDF721A7-CD06-4D6B-B643-2C326D9EA8F1Q37650208-C3BE580E-4185-4E2D-AC17-49D55D4E2BC7
P2860
Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Are cross-species measures of ...... otreatments for schizophrenia?
@ast
Are cross-species measures of ...... otreatments for schizophrenia?
@en
type
label
Are cross-species measures of ...... otreatments for schizophrenia?
@ast
Are cross-species measures of ...... otreatments for schizophrenia?
@en
prefLabel
Are cross-species measures of ...... otreatments for schizophrenia?
@ast
Are cross-species measures of ...... otreatments for schizophrenia?
@en
P2860
P1476
Are cross-species measures of ...... otreatments for schizophrenia?
@en
P2093
Mark A Geyer
P2860
P577
2006-01-01T00:00:00Z